project Feasibility of Targeting Intimal Hyperplasia and Vascular Calcification for the treatment of Coronary Artery Disease via the Inhibition of ADAMTS-7 with Precision-Directed Catalytic Cleft-Binding Antibodies.

Project: Research

Project Details


This application is a 6 month collaborative project with VASGEN Ltd to develop and characterise prototype antibody inhibitors of the ADAMTS-7 protease. Vasgen will licence its antibody technology to UH to develop the antibodies and characterise them biochemically and functionally in vitro. the project could lead to further collaborative studies aimed to develop a therapeutic lead and clinical strategy.
Short titleADAMTS-7 Inhibition In CAD
Effective start/end date1/06/2231/12/22


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.